Yue Yuan
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Functional and Mechanistic Explanation for the Unique Clinical Success of the Glucokinase Activator Dorzagliatin in the Treatment of Type 2 Diabetes.
Journal: Diabetes
Published: January 21, 2025
Knowledge, Attitude, and Practice Toward Hyperuricemia Among Patients Diagnosed with Hyperuricemia.
Journal: Journal of multidisciplinary healthcare
Published: December 17, 2024
Prolactin deficiency drives diabetes-associated cognitive dysfunction by inducing microglia-mediated synaptic loss.
Journal: Journal of neuroinflammation
Published: September 18, 2024
Identification of adipose tissue-derived exosomal microRNA as a novel causal biomarker for cognitive impairment in type 2 diabetes mellitus: Triangulating evidence from Mendelian randomization and multicentre population studies.
Journal: Diabetes, obesity & metabolism
Published: September 05, 2024
Placenta-derived exosomes exacerbate beta cell dysfunction in gestational diabetes mellitus through delivery of miR-320b.
Journal: Frontiers in endocrinology
Published: August 23, 2023
Metabolic regulator LKB1 controls adipose tissue ILC2 PD-1 expression and mitochondrial homeostasis to prevent insulin resistance.
Journal: Immunity
Published: August 18, 2023
Single-cell analysis reveals a subpopulation of adipose progenitor cells that impairs glucose homeostasis.
Journal: Nature communications
Published: August 04, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026